Growth Capital • Software

Avista Healthcare Partners Invests In eMolecules

On March 25, 2021, private equity firm Avista Healthcare Partners invested in software company eMolecules

Investment Context
  • This is Avista Healthcare Partners’ 1st transaction in the Software sector.
  • This is Avista Healthcare Partners’ 39th transaction in the United States.
  • This is Avista Healthcare Partners’ 6th transaction in California.

Explore All 1293 Growth Capital Software Deals - Search the Database Free


Investment Summary

Date March 25, 2021
Target eMolecules
Sector Software
Investor(s) Avista Healthcare Partners
Deal Type Growth Capital
Advisor(s) Baird (Financial)
Paul Hastings (Legal)

Target Company

eMolecules

San Diego, California, United States
eMolecules provides business intelligence data and integrated ecommerce software for screening compound, chemical building blocks and primary antibody supply chains. eMolecules was founded in 2005 and is based in San Diego, California.
Explore More Deals

Browse All 215,158 Deals

FILTER BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Search Free

Investor Overview 1

Investor

Avista Healthcare Partners

New York, New York, United States

Category Private Equity Firm
Founded 2005
PE ASSETS 8.0B USD
Size Mega
Type Sector Focused
DESCRIPTION

Avista Capital Partners is a private investment firm formed by a group of professionals with roots from DLJ Merchant Banking Partners. Avista makes controlling and minority investments in US based energy, healthcare, and media companies with revenues greater than $25 million. Typical transactions include leverage buyouts, build-ups, and growth capital financings. Avista Capital was formed in 2005 and is based in New York City with an additional office in Houston, Texas.


Deal Context for Investor #
Overall 48 of 56
Sector: Software 1 of 1
Type: Growth Capital 5 of 6
State: California 6 of 6
Country: United States 39 of 44
Year: 2021 2 of 2
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2021-03-12 Cooper Consumer Health

Paris, France

Cooper Consumer Health is an independent OTC drug manufacturer and distributor. It operates a distinctive business model with a unique distribution network and sales force accessing all 22,000 pharmacies. Cooper Consumer Health is based in Paris, France.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2021-08-09 Arcadia Consumer Healthcare

Bridgewater, New Jersey, United States

Arcadia Consumer Healthcare focuses on the development, marketing and distribution of over-the-counter medicines, premium vitamins, minerals and supplements across consumer health and personal care categories. The Company offers product lines addressing hair & scalp care, digestive health, foot care, oral care, cough & cold relief, and vitamins/minerals. Arcadia Consumer Healthcare is based in Bridgewater, New Jersey.

Sell -